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Objective: Long-term organ preservation for transplantation may allow optimal do-
nor–recipient matching with potential reduction in the incidence and severity of rejec-
tion. Complete cessation of metabolism may be obtained by freezing. Previous
attempts to freeze intact mammalian hearts were limited to23.6C, restricting tissue
ice content to 34%. We hypothesized that our method will allow recovery of function
of the intact rat heart after freezing to28C, a temperature at which most of the tissue
water is frozen.
Methods: Isolated rat hearts were attached to a Langendorff apparatus. After normo-
thermic perfusion, cold cardioplegia was induced followed by perfusion with a cryo-
protecting agent. Hearts were than frozen to 28C (45 6 8 minutes), thawed, and
reperfused (60 minutes).
Results: All frozen and thawed hearts regained normal electric activity. At28C, ice
content was 64.36%6 13%. The use of 10% ethylene glycol for cryoprotection (n5
13) resulted in recovery (mean 6 standard deviation) of 49.7% 6 21.8% of 1dP/dt,
48.0%6 23.5% of –dP/dt, 65.2%6 30.8% of coronary flow, and 50.4%6 23.9% of
left ventricular developed pressure. Hearts in this group (n5 4) maintained 81.3%6
10% viability compared with 69.3%6 14% (not significant) in control hearts kept at
0C for the same duration. Energy stores, represented by adenosine triphosphate and
phosphocreatine, were depleted to 12.2 6 6.1 mmol/g dry weight and 22.5 6 6.4
mmol/g dry weight, respectively, compared with 19.0 6 2.5 mmol/g dry weight and
36.66 3.0 mmol/g dry weight, respectively (P, .05) in the control hearts. The integ-
rity of muscle fibers and intracellular organelles after thawing and reperfusion was
demonstrated by electron microscopy.
Conclusion: We demonstrate for the first time the feasibility of functional recovery
after freezing and thawing of the isolated rat heart while maintaining structural integ-
rity and viability.
L
ong-term organ preservation without tissue injury may open new horizons in
the treatment of important medical problems. Hypothermic organ preservation
for transplantation restricts the ischemic time for donor hearts or lungs to only
a few hours, precluding donor–recipient matching between remote places. Because of
these time constraints, matching is limited to only blood type and body size. The pro-
longation of organ preservation may allow optimal immunologic matching of the do-
nor with potential recipients. This in turn could lead to reduction of the incidence of
rejection and the intensity of immunosuppression needed after transplantation and,
ultimately, lower costs of care with improved results.
Hypothermia, used for thoracic organs preservation, does not stop metabolism, but
it slows biochemical reactions and decreases the rate at which intracellular enzymes
degrade essential cellular components necessary for organ viability. Total cessation
of metabolism could be obtained by freezing of these organs. However, previous
attempts to freeze intact mammalian hearts were limited to a minimal temperature of
23.6C to restrict tissue ice content to less than 40%, resulting in supercooling of
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TXAbbreviations and Acronyms
EG 5 ethylene glycol
HR 5 heart rate
KH 5 Krebs–Henseleit
LVDP 5 left ventricular developed pressure
MTT 5 methylthiazoldiphenyl-tetrazolium bromide
UW 5 University of Wisconsin
the rest of tissue water and avoiding the destructive effects of
release of latent heat and induction of isothermal period char-
acterizing the initiation of the freezing process. The recovery
of cardiac output in these hearts after 6 hours was 50%.1,2 By
using a novel freezing method and microsurgical techniques,
we recently demonstrated the ability to preserve hormonal
activity and ovulation after autotransplantation of frozen-
thawed ovaries in sheep.3,4 In the present study, using a mod-
ification of our freezing method, we demonstrate the potential
for functional recovery and preservation of structural integ-
rity and energy stores and maintenance of tissue viability of
isolated rat hearts subjected to freezing to 28C with tissue
ice content of more than 60%.
Materials and Methods
Solutions
Modified Krebs–Henseleit (KH) solution was prepared daily ac-
cording to Neely and Rovetto,5 containing the following: 118
mmol/L NaCl, 4.9 mmol/L KCl, 1.2 mmol/L MgSO4, 1.2 mmol/L
KH2PO4, 25 mmol/L NaHCO3, 11.1 mmol/L glucose, and 2.5
mmol/L CaCl2.
University of Wisconsin (UW) ViaSpan was obtained from
Bristol-Myers-Squibb Company, Princeton, NJ.
Ethylene glycol (EG) (Sigma-Aldrich Israel Ltd, Rehovot, Is-
rael) was added to the UW solution to obtain a final concentration
of 5% or 10% in the UWEG solution delivered to the hearts before
freezing.
For the methyl-thiazol-diphenyl-tetrazolium (MTT) assay, glu-
cose phosphate-buffered saline was prepared daily in distilled water
and contained 136.9 mmol/L NaCl, 2.68 mmol/L KCl, 8.10 mmol/L
Na2HPO4, 1.53 mmol/L KH2PO4, 0.5 mmol/L MgCl2, 0.9 mmol/L
CaCl2, and 5.55 mmol/L glucose (pH 7.45).
Isolated Heart Perfusion
Male Sprague Dawley rats weighing 280 6 20 g were used for the
experiments. Handling of the animals was in accord with the Guide
for the Care and Use of Laboratory Animals published by the U.S.
National Institutes of Health (Publication No. 85-23, revised 1996).
The animals were intraperitoneally injected with sodium heparin
(500 U) and 30 minutes later were anesthetized with pentobarbital
(30 mg/animal). The hearts were immediately removed and placed
in heparinized ice-cold saline solution. The aorta was cannulated
to a Langendorff perfusion apparatus, and the pulmonary artery
was cut open to provide drainage.
Retrograde aortic perfusion was maintained with a modified KH
solution and aerated with a mixture of 95% (v/v) oxygen and 5%The Journal of Thor(v/v) carbon dioxide. The initial aortic perfusion (KH solution)
was maintained at 37C and a pressure of 90 cm H2O.
Hemodynamic Measurements
Hemodynamic parameters were monitored using a latex balloon-
tipped catheter inserted through an incision in the left atrium and
advanced through the mitral valve into the left ventricle and
connected to a pressure transducer placed at equivalent height to
the heart and a recording system (PowerLab, ADInstruments, Bella
Vista NSW, Australia). The balloon was inflated and equilibrated to
give an end-diastolic pressure of 0 mm Hg. Left ventricular systolic
and diastolic pressures and time derivatives of pressure were mea-
sured during contraction (1dP/dt) and relaxation (2dP/dt). Left
ventricular developed pressure (LVDP) was calculated as the differ-
ence between the systolic and diastolic pressures. The work index of
the heart (LVDP3 heart rate [HR]) was derived from the product of
LVDP and HR. Coronary flow rate was measured by collecting the
effluent drained through the pulmonary artery during precooling/
freezing and during reperfusion.
Assessment of Ethylene Glycol Toxicity
A series of experiments was performed to assess the toxicity of the
different EG concentrations (see Appendix E1 for results).
Assessment of Tissue Ice Content
Tissue ice content was determined by calorimetry as previously de-
scribed.6,7 Immediately after reaching the desired temperature, the
heart was transferred to a glass vacuum-isolated calorimeter. The
change in water temperature after the introduction of the frozen heart
was digitally recorded using a thermocouple connected to a digital
thermometer. The ice content of the frozen heart was calculated
using the following equation:
Wi 5
F ðWwÞ ðSwÞ ðTi2TfÞ1ðTs2TfÞ ½ðWdÞ ðSdÞ1ðWsÞ ðSwÞ
ðTs2TfÞ ðSwÞ 1 Q 1 Si ðMp2TsÞ 1 Sw ðTf2MpÞ
Where: F5 calorimeter constant5 0.65, Mp5melting point of tis-
sue fluids (C) 5 20.8, Q 5 heat of fusion of water (79.7 cal/g 3
C), Sd5 specific heat of the dry tissue (0.3 cal/g3 C), Si5 spe-
cific heat of ice (0.5 cal/g3 C), Sw5 specific heat of water at 20C
(0.9988 cal/g 3 C), Tf 5 final temperature of the water in the cal-
orimeter (C), Ti5 initial temperature of the water in the calorimeter
(C), Ts 5 temperature of the tissue, Wd 5 weight of tissue dry
mass (g), Wi 5 weight of ice in tissue (g), Ws 5 weight of water
in tissue (g), and Ww5 weight of water in the calorimeter (g). Six-
teen hearts were used to determine ice content at 0C (2), 23.5C
(6),28C (6), and220C (2). The tissue ice content was expressed
as a percentage of total tissue water.
Experimental Protocol
Hearts were subjected to 20 minutes of perfusion (KH, 37C) for ba-
sic hemodynamic measurements. The latex balloon was removed,
and a thermocouple was inserted into the left ventricle through the
left atrium to monitor endocardial temperature. Cold cardioplegia
(4C) was perfused (via the side arm) for 1 minute (10 mL UW), fol-
lowed by 10 mL perfusion of either UW 1 EG 5% (UW EG 5%,
group 1, n 5 8) or UW 1 EG 10% (UW EG 10%, group 2, n 5
13) for 3 minutes. The heart was disconnected from the perfusionacic and Cardiovascular Surgery c Volume 135, Number 3 667
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desired endocardial temperature of28C (range –7C to –10C, 45
6 8 minutes), the frozen hearts were thawed in saline solution at
37C for 20 to 30 seconds and reattached to the perfusion system
for 60 minutes of normothermic reperfusion with KH. The latex bal-
loon was reinserted into the left ventricle and reinflated to identical
volume as during the preischemic period. Hemodynamic measure-
ments at the end of the normothermic reperfusion were compared
with the basic measurements taken before freezing, each heart serv-
ing as a control for itself. Four hearts perfused for 20 minutes at nor-
mothermia were arrested with UW solution, kept ischemic while
immersed in UW solution (0C, 50 minutes), and reperfused with
KH solution for 60 minutes (control).
After conclusion of the reperfusion procedures, while the hearts
were still beating, left ventricular slices (1 cubic mm) were taken for
electron microscopy. Slices from these hearts were removed for
viability test and analyzed by methythiazoldiphenyl-tetrazolium
bromide (MTT, Sigma Chemical Co, St Louis, Mo).8 The beating
hearts were than rapidly frozen, and adenosine triphosphate and
phosphocreatine were extracted with perchloric acid and determined
enzymatically.9,10
The baseline values for high-energy phosphate content and tissue
viability were also determined in a group of rat hearts (n 5 6) not
exposed to ischemia and reperfusion (preischemia control).
Freezing Process
Freezing was performed using a novel freezing device (Core
Dynamics Ltd, Ness Ziona, Israel) based on directional freezing
technology (patent pending). In brief, the device is built with
temperature domains within two 70-mm brass blocks. The freezing
device was precooled to 0C and remained at that temperature for at
least 20 minutes before onset of the freezing process. A thermocou-
ple was inserted into the left ventricle through the incision in the left
atrium to monitor myocardial temperature. The heart was placed at
the center of the freezing chamber and immersed in UWEG solution.
Initial cooling at a rate of20.5C/min was controlled by setting the
temperature of the brass blocks to 25C, followed by reduction of
the temperature of the device to 210C to increase the cooling rate
to21.0 C/min. The final myocardial temperature of28C was ac-
complished by cooling the device to as low as215C. Thawing was
performed by plunging the freezing chamber into a saline bath at
37C for 256 5 seconds until the heart separated from the surround-
ing ice.
To ascertain that freezing was uniform and transmural, and to ex-
clude the possibility that the myocardium itself was only super-
cooled, a separate experiment was performed with simultaneous,
direct measurement of the intramyocardial temperature and the
temperature in the left atrium (Figure 1).
Adenosine Triphosphate and Phosphocreatine
Determination
At the end of reperfusion, the hearts were rapidly frozen with stain-
less-steel blocks precooled in liquid nitrogen. Perchloric acid ex-
tracts were prepared from tissue samples according to the method
of Lowry and Passonneau.9 Adenosine triphosphate and phospho-
creatine levels were assessed by the enzymatic assay of Lampecht
and Stein,10 and expressed as micromoles per gram of dry weight
of myocardial tissue (dried at 90C for 24 hours).668 The Journal of Thoracic and Cardiovascular Surgery c MaAssessment of Tissue Viability by MTT
At the end of the experimental protocol, tissue viability was deter-
mined by MTT staining: reduction of 3-[4,5 dimethylthiazol-2yl]-
2.5 diphenyltetrazolium bromide to blue formazan by mitochondrial
dehydrogenases. The intensity of MTT staining in the myocardial
slices is correlated with the viability of the tissue.8
Ventricular slices of 1-mm thickness were incubated in 20 mL of
glucose phosphate-buffered saline containing MTT (0.5 mg/mL) at
37C for 90 minutes under a mild flow of oxygen. The slices were
then transferred to a small test tube containing 3 mL of phos-
phate-buffered saline, which was shaken for 1 minute to remove
excess dye. The slices were transferred into tubes with dimethyl
sulfoxide and homogenized for 10 seconds using a HG-300 Homog-
enizer (Hsiangtai Machinery Industry Co, Ltd, Taiwan). Extraction
of the formazan dye into dimethyl sulfoxide was done with vigorous
shaking for 1 hour at 37C. The homogenate was centrifuged for 10
minutes at 4000g, and the colored supernatant was measured spec-
trophotometrically at 500 nm. The slices were dried in a 90C oven
for 24 hours, and the results were expressed as optical density per
milligram of dry weight of myocardial tissue. Tissue viability was
expressed as the ratio between the optical density of treated hearts
to that of its aerobic controls (8 control hearts perfused with KH
for 20 minutes 5 100% viability), normalized to the dry weight of
the myocardial tissue.
Electron Microscopy
The heart slices were fixed and processed for electron microscopy as
described by Gilead and colleagues.11
Statistical Analysis
Hemodynamic and metabolic parameters are expressed as means6
standard deviation. The statistical significance of the differences
Figure 1. Freezing curves of the rat hearts. The line representing
the temperature curve during conventional freezing of a rat heart
(control) demonstrates a long isothermal period. The arrow points
to where the release of latent heat at sub-zero temperature is
evident. By using our novel freezing method in a separate exper-
iment, intramyocardial temperature was measured simulta-
neously with atrial temperature to verify uniform transmural
cooling and freezing.rch 2008
Elami et al Cardiothoracic TransplantationTABLE 1. Hemodynamic recovery (%) after freezing (28C, 48 6 5 minutes), thawing, and normothermic reperfusion (60
minutes)
Preischemic hemodynamic parameters and recovery (%) after freezing to 28C and thawing (M 6 SD)
Group 1 UW 1 EG 5% (n 5 8) Group 2 UW 1 EG 10% (n 5 13)
Preservation conditions Preischemia Reperfusion (%) Preischemia Reperfusion (%)
1 dP/dt 2247 6 365 26.8 6 14.5 2287 6 512 49.7 6 21.8*
2dP/dt 1934 6 385 24.9 6 13.6 1939 6 436 48.0 6 23.5*
CF 13.6 6 2.6 81.0 6 20.3 13.0 6 2.8 65.2 6 30.8
HR 268 6 28 92.3 6 16.5 264 6 41 88.6 6 14.2
LVDP 123 6 11.5 27.4 6 14.6 126 6 26 50.4 6 23.9
LVDP 3 HR 33,327 6 5293 25.6 6 14.1 32,902 6 7063 43.3 6 20.0
SD, Standard deviation; EG, ethylene glycol; UW, University of Wisconsin; CF, coronary flow; HR, heart rate; LVDP, left ventricular developed pressure. Prei-
schemic hemodynamic units: dP/dt5mmHg/sec; CF5mL/min; HR5 beats/min; LVDP5mmHg; LVDP3 HR5mmHg3 beats/min. *P,.05 versus group 1.TXbetween samples was evaluated using 1-way analysis of variance
followed by the Mann–Whitney rank test for post hoc analysis.
Results
All hearts in the 2 study groups regained contractile function
after freezing and thawing. The recovery of hemodynamic
parameters is presented as the percentage of the original func-
tion after harvest and stabilization for the 2 study groups
(Table 1). The recovery of parameters representing systolic
and diastolic function (1dP/dt and2dP/dt) was significantly
better (P, .05) among hearts frozen with 10% EG (group 2)
than among the hearts frozen with 5% EG (Table 1). The
spontaneous beating rate (HR) of the frozen and thawed
hearts recovered to high levels of 88.6% 6 14.2%. Control
hearts (n 5 4), not subjected to freezing and kept at 0C
for 50 minutes, recovered 64.4% 6 13.3% of their preische-
mic1 dP/dt, 62.3%6 15.0% of2dP/dt, 87.0%6 16.8% of
coronary flow, 111.9% 6 20.6% of HR, 61.1% 6 10.5% of
LVDP, and 70.0%6 23.4% of the preischemic LVDP3HR.
Figure 2 demonstrates a representative freezing and thaw-
ing experiment. A regular (no arrhythmia) beat-to-beat trace
of the systolic and diastolic pressures is presented during the
preischemic perfusion and the post-freezing reperfusion.
The uniformity of our freezing process across the ventric-
ular wall is depicted in Figure 1. No temperature gradients
were detected between the myocardium and the endocar-
dium, excluding the possibility of super-cooling rather than
freezing of the myocardium. Figure 1 indicates (in group 2
hearts, frozen with 10% EG using our special device) the
avoidance of a harmful isothermal period secondary to the re-
lease of latent heat, resulting in freezing at a predetermined
cooling rate, in contrast with a super-cooling phenomenon
shown during conventional freezing (control).
The decreased energetic reserve of the frozen and thawed
hearts of group 2 (UW1 EG 10%), as reflected by adenosine
triphosphate and phosphocreatine levels, is presented in Ta-
ble 2. Both adenosine triphosphate and phosphocreatinine
were significantly lower than during the preischemic period,The Journal of Thorbut when compared with hearts that were not subjected to EG
and freezing and were preserved at 0C, only phosphocrea-
tine was significantly lower (P , .05; Table 2).
The tissue viability of hearts of group 2 (n 5 4), as dem-
onstrated by the MTT test, is shown in Table 2. Good viabil-
ity was found for the frozen, thawed, and reperfused hearts of
group 2 (81.3% 6 10%); although the viability was better
than that of the control group, preserved at 0C (69.3% 6
14%), the difference was not significant (Table 2). A small
sample (n 5 2) of group 1 hearts confirmed that not only
the hemodynamic results were inferior after the freezing
and thawing process (Table 1) but also the protection as
reflected by the biochemical analysis (Table 2).
The integrity of the muscle fibers and intracellular organ-
elles after thawing and reperfusion is demonstrated by elec-
tron microscopy in Figure 3, which demonstrates regular
arrays of myofibrils, divided into sarcomeres. It shows nu-
merous intact mitochondria between the myofibrils and the
presence of T-tubules (T) that penetrate into the muscle at
the level of the Z-bands. We did not find any precipitations
of Ca21 in the mitochondria, as was found for hearts sub-
jected to normothermic ischemia and reperfusion.
The cooling of hearts perfused with UWEG 10% to
23.5C resulted in only partial freezing (super-cooling) of
the tissue water rendering more than 80% of the water
unfrozen. At 28C, with the use of our novel freezing
method, the hearts reached an ice content of 64.36% 6
13.18% (Table 3).
Discussion
Previous studies in cryopreservation of the explanted rat
heart attempted to mimic the adaptive strategies for natural
freeze tolerance that had been described in amphibians and
reptiles.12 Slow cooling (0.18C/min) was limited to a tem-
perature that would restrict tissue ice formation to less than
40%.1 This level of freezing was believed to be the highest
level that could be tolerated by the rat heart.13 By using var-
ious cryoprotective agents to supplement the cardioplegicacic and Cardiovascular Surgery c Volume 135, Number 3 669
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TXFigure 2. Representative freezing and thawing
(UW 1 EG 10%) experiment. Real-time prog-
ress of the experiment is presented along the
X axis, and the intraventricular pressure (sys-
tolic and diastolic, mm Hg) is shown on the Y
axis. The perpendicular dark line at the center
of the chart represents the freezing of the heart
(28C, 48 minutes). A regular (no arrhythmia)
beat-to-beat trace of the systolic and diastolic
pressures during preischemic perfusion and
post-freezing reperfusion is presented on the
chart.solution, different thawing rates, and an isolated working
heart model, these researchers demonstrated up to 60%
recovery of function as measured by cardiac output.2 Their
target temperature was, however, 23.4C, which resulted in
freezing of only 34% of the tissue water.2
We demonstrate for the first time that recovery of function
is possible after freezing of the rat heart to –8C (or even
210C), which resulted in more than 60% ice content. On
the basis of our previous experience with ovarian freezing,
we elected to use EG as a cryoprotective agent and found
that adding 10% EG to our cardioplegic solution (UW)
yielded the best recovery after freezing to 28C.
The recovery of function after freezing and thawing was
probably the result of the unique freezing method used in
our experiment. The process of ice formation begins with
the creation of an ice nucleus (ie, 1 ice crystal). Along with
the decrease in temperature, more and more ice crystals
join this first ice focus, leading to ongoing growth of a large
ice front. This procedure is complete when all of the water in
the sample to be frozen is turned into ice. Our method is
based on 2 principles. It allows controlled direction of the
ice front from epicardium to endocardium, thereby maintain-
ing 1 direction of freezing in a precise cooling rate, which
avoids the formation of intracellular ice. Second, we believe
that efficient release of latent heat during the freezing process670 The Journal of Thoracic and Cardiovascular Surgery c Maris of paramount importance. The use of conventional freezing
is associated with a long and potentially destructive isother-
mal period resulting from the release of the latent heat. In
the present study, we used 2 foci of simultaneous nucleation
because our preliminary experience indicated that this was
preferable to a single focus of nucleation (data not shown).
Our hypothesis regarding this phenomenon is that by using
2 foci simultaneously we rendered the evacuation of latent
heat more efficient, thereby shortening the duration of the
isothermal period.
As noted earlier, the spontaneous beating rate (HR) of the
frozen and thawed hearts recovered to high levels of approx-
imately 90%. This is important, because it means that the
pacemaker and conductance system of the heart are practi-
cally unaffected by the freezing and thawing process. Energy
stores of the frozen and thawed hearts were significantly de-
pleted compared with the control hearts. This could be due to
the toxic effect of EG during the period between induction of
cardioplegic arrest and reaching the frozen state, or during the
time between thawing and complete rinsing of the EG on re-
perfusion. It should be noted, however, that although energy
stores were significantly depleted, viability was maintained
(81.3% 6 10% by MTT assay), indicating intactness of cel-
lular membranes with preservation of the nucleotides nicotin-
amide adenine dinucleotide/reduced nicotinamide adenineTABLE 2. Energy stores and viability before ischemia and after cooling or freezing followed by normothermic reperfusion
Group 1 UW 1 EG 5%,
28C (n 5 2)
Group 2 UW 1 EG 10%,
28C (n 5 4)
Control UW,
0C (n 5 4)
Preischemic Control,
37C (n 5 6)
ATP 3.9, 5.4 12.2 6 6.1 19.0 6 2.5 21.3 6 5.1
Phosphocreatine 12.7, 15.6 22.5 6 6.4* 36.6 6 3.0 32.8 6 7.9
Viability (%) 76%, 76% 81.3% 6 10% 69.3% 6 14% 100%
UW, University of Wisconsin; EG, ethylene glycol; ATP, adenosine triphosphate. ATP and phosphocreatine (mmol/g dry weight); viability (MTT assay) was
measured as described in "Materials and Methods." *P , .05 versus control. The difference between group 2 and the preischemic control was significant
for all parameters.ch 2008
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phosphorylation.
Nevertheless, although the initial results are encouraging,
we observed a significant decay of function after reperfusion
of the thawed hearts. Possible ways to improve the preserva-
tion of function after freezing and thawing should address the
toxic effects of EG. A lower concentration of EG may be less
toxic to the tissue; however, the protection afforded by this
concentration while freezing to complete icing of tissue water
is insufficient. Therefore, a better freezing solution should be
designed to reduce toxicity but at the same time allow enough
freezing protection.
The rapid thawing rate was implicated as responsible for
the reduction of viability and function in some models.14-16
However, cell swelling subsequent to rapid thawing did not
occur in the defrosted hearts, according to electron micros-
copy findings. Initial reperfusion with UW solution rather
Figure 3. Longitudinal section of left ventricular muscle after
freezing in UW and 10% EG, thawing, and normothermic reperfu-
sion. The section is showing regular arrays of myofibrils, divided
into sarcomeres. Note the presence of numerous intact mitochon-
dria between the myofibrils and the presence of T-tubules (T),
which penetrate into the muscle at the level of the Z-bands
(321,000).The Journal of Thorthan with KH solution may be tested in an attempt to mini-
mize the potential for rapid dilution of the intra- and extracel-
lular solutes.
In our freezing process, ice crystals were formed only in
the extracellular space and within the blood vessels. Endothe-
lial damage secondary to the formation of these crystals
within the coronary arteries could account for uneven reperfu-
sion and loss of function. Cryopreservation of canine coro-
nary arteries to 275C in the presence of dimethyl
sulfoxide and fetal calf serum for 7 days resulted in a loss of
only 15% to 20% of the endothelium-dependent vasodilatory
response.17 However, quantitative assessment of human cor-
onary and mesenteric arteries after cryopreservation to
2196C using dimethyl sulfoxide with or without fetal calf
serum as a cryoprotective agent revealed marked endothelial
denudation and diminished contractile (62% of control) and
endothelium-dependent relaxant (26%–38%) responses of
these arteries.18 Such damage could have accounted for the
failure of some of the ovaries retransplanted after freezing
in our previous experience3,4 and for the marked depletion
of energy stores in underperfused zones in the frozen and
thawed hearts in the present study. The morphologic and func-
tional recovery of coronary arteries frozen according to our
protocol will be the focus of a separate series of experiments.
Conclusions
We demonstrated the feasibility of functional recovery after
freezing and thawing of the heart. In addition, we demon-
strated structural integrity and energy production during the
reperfusion. Additional studies are needed for decreasing
the toxicity of the preservation solution and improving the
functional recovery.
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Elami et al Cardiothoracic TransplantationAppendix E1
Effect of EG toxicity (5% and 10% EG). The hearts were perfused
for 20 minutes at 37C (KH) and then arrested with UW solution
(10 mL, 4C for 1 minute), followed by 10 mL of cold (4C) UW
1 EG 5% (control EG 5%, n 5 6) or UW 1 EG 10% (control
EG 10%, n 5 8) administered for 3 minutes. The hearts were then
immersed in UW solution at 4C to complete 25 minutes of ischemia
since the end of initial perfusion period. This was followed by 60
minutes of normothermic reperfusion (KH). Hearts perfused for
20 minutes at 37C (KH) and then arrested with UW solution (10
mL, 4C for 1 minute) and immersed in UW solution to complete
25 minutes of ischemia followed by normothermic reperfusion for
60 minutes served as the control for the solution effect (control
EG 0%, n 5 6).
Although the addition of 10% EG to the UW solution yielded
a significantly improved functional recovery of the frozen and
thawed hearts, this concentration of EG was more toxic to the hearts
kept ischemic at 4C (toxicity is temperature dependent). This was
mainly evident for the –dP/dt and coronary flow (Table E1). The re-
covery of the spontaneous beating (HR) was less affected by the tox-
icity of EG.The Journal of ThoracTABLE E1. Toxicity effect of ethylene glycol on
hemodynamic recovery (%) after cold ischemia (25
minutes, 4C) and normothermic reperfusion
Hemodynamic recovery (M 6 SD %)
Control EG 5%
(n 5 6)
Control EG 10%
(n 5 8)
Control EG 0%
(n 5 6)
1 dP/dt 83.9 6 14.5 66.4 6 15.1 91.7 6 22.4
2dP/dt 83.2 6 10.1 65.5 6 16.9*y 88.0 6 19.2
Coronary flow 91.5 6 32.4 65.5 6 15.3* 92.4 6 28.0
HR 102.3 6 12.0 92.9 6 14.9 90.0 6 15.5
LVDP 83.0 6 15.6 65.3 6 14.1 90.8 6 21.0
LVDP 3 HR 84.9 6 18.0 61.5 6 20.7 82.3 6 25.4
SD, Standard deviation; EG, ethylene glycol;HR, heart rate; LVDP, left ventric-
ular developed pressure. *P , .05 versus control. yP , .05 versus group 1.TX
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